Avandamet Supply Issues Are Resolved, Allowing Launch Of New Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline's announcement about renewed Avandamet availability follows the approval of the type 2 diabetes drug for first-line use.